Project Grant K01HG013687
Award Date
8/7/24
Completion Date
5/31/29
Dollars Obligated
$205K
Federal Agency
National Human Genome Research Institute
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) will support the development of a one-year Master of Science (MS) program in Genomic Medicine for UCSF medical students. The $485,847 award, with a period of performance from September 2024 to August 2027, will fund the creation of innovative educational strategies and course content to train future physicians in the clinical applications of genetics and genomics. Key focus areas will...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $716,587 to Boston Children's Hospital to advance equity in rare disease genomic research. The key objectives are to: Develop and implement a Diversity, Equity, and Inclusion toolkit within the Broad Institute's Rare Genomes Project to improve engagement and participation from historically underrepresented populations in rare disease genomic studies. This will involve...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) is focused on generating strategies and resources to facilitate informed decision-making for pregnant patients regarding prenatal genetic screening and diagnostic tests (PS&D). The $831,046 award, effective September 18, 2024 through August 31, 2025, aims to: Determine how changes in PS&D and post-diagnosis options affect the resources and support patients need for informed...
This $370,716 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of an implementation guide to facilitate the integration of population-wide genomic screening (PGS) programs across diverse settings. The "Facilitating the Implementation of Population-Wide Genomic Screening Across Diverse Populations and Settings (FOCUS)" project aims to: Conduct a qualitative needs assessment of 10 existing PGS programs to...
This federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $159,803 to the Regents of the University of Michigan to incorporate emerging genomic, transcriptomic, epigenomic, and proteomic technologies for the analysis of advanced, rare, and pediatric cancers. The project aims to translate these new analytical approaches into clinically actionable information through the development of reportable test results in the...
This federal Project Grant award from the National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research) provides $391,703 to The Regents of the University of California, San Francisco (UCSF) from May 1, 2025 to April 30, 2028. The funding supports the development of rapid, sensitive, and reproducible drug screening platforms using patient-derived organoids (PDOs) for breast cancer research. The project aims to improve the uniformity and predictive power of PDO models through...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) will provide $291,643 to Nest Health TECH Inc. (Nest Genomics) to develop and study a software platform that delivers longitudinal, genetics-based care at scale. The platform will integrate with electronic medical records (EMRs) to store structured genetic results, provide clinicians with clinical decision support tools for guideline-informed and patient-specific care management...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) to the University of California, Davis is focused on understanding the role of gene-gene interactions (epistasis) in genetic prediction and portability across diverse ancestral populations. The $281,751 award, with a project period from September 1, 2024 to August 31, 2026, will enable the researchers to generate a large genome-wide methylation dataset from 500 admixed South African...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $812,957.00 over 5 years (1/1/2025 - 12/31/2029) to The University of Texas Southwestern Medical Center to develop a framework of principles to guide ongoing policy development around variant reinterpretation, reclassification, and recontact in medical genetics. The project involves qualitative research methods including focus groups, deliberations, and a Delphi panel with...
This National Cancer Institute (NCI) Project Grant award, under the Cancer Research Manpower (CFDA 93.398) program, provides $128,509.00 to the University of California, Los Angeles (UCLA) from April 1, 2025 to March 31, 2027. The award supports the development of "TreatMonitor", a computational system for ultrasensitive, comprehensive, and affordable cancer monitoring using multi-omics profiling of cell-free DNA (cfDNA). The project aims to improve minimal residual disease (MRD) and...